Bjarred, Sweden

Charlotte Wiberg


Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 71(Granted Patents)


Location History:

  • Bjaerred, SE (2015)
  • Bjärred, SE (2019 - 2021)
  • Bjarred, SE (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Charlotte Wiberg

Introduction

Charlotte Wiberg is a prominent inventor based in Bjarred, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for treating inflammatory diseases. With a total of nine patents to her name, Wiberg's work has the potential to impact the lives of many individuals suffering from conditions such as rheumatoid arthritis and inflammatory bowel disease.

Latest Patents

Wiberg's latest patents include groundbreaking inventions such as the site-directed mutagenesis of TREM-1 antibodies for decreasing viscosity. These antibodies are designed to specifically bind and prevent the activation of TREM-1, a protein expressed on monocytes, macrophages, and neutrophils. The antibodies exhibit good affinity and low viscosity at clinically relevant concentrations, making them useful in treating inflammatory diseases. Another notable patent involves nucleic acids encoding antibodies that bind and block the triggering receptor expressed on myeloid cells-1 (TREM-1). This invention also focuses on the treatment of individuals with inflammatory diseases, showcasing Wiberg's commitment to advancing medical science.

Career Highlights

Charlotte Wiberg is currently associated with Novo Nordisk A/S, a leading global healthcare company. Her work at Novo Nordisk has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to biotechnology and medicine.

Collaborations

Some of Wiberg's notable coworkers include Vibeke Westphal Stennicke and Anette Henriksen. Their collaborative efforts have played a crucial role in the development of innovative solutions in the field of antibody research.

Conclusion

Charlotte Wiberg's innovative work in the field of biotechnology, particularly in the development of antibodies for inflammatory diseases, highlights her significant contributions as an inventor. Her patents and collaborations reflect her dedication to improving healthcare outcomes for individuals with chronic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…